I agree that this site is using cookies. You can find further informations here.
X
Tébar-García, David
107  results:
Search for persons X
?
1

TACkling Cancer by Targeting Selective Protein Degradation:

Noblejas-López, María del Mar ; Tébar-García, David ; López-Rosa, Raquel...
Pharmaceutics.  15 (2023)  10 - p. 2442 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Posi..:

Noblejas-López, María del Mar ; Gandullo-Sánchez, Lucía ; Galán-Moya, Eva M....
International Journal of Molecular Sciences.  23 (2022)  10 - p. 5476 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Pathogenic Microenvironment from Diabetic–Obese Visceral an..:

Alviz, Lesgui ; Tebar-García, David ; Lopez-Rosa, Raquel...
Nutrients.  13 (2021)  3 - p. 1032 , 2021
Link: https://doi.org/10.3390/..
 
?
4

MZ1 co-operates with trastuzumab in HER2 positive breast ca..:

Noblejas-López, María del Mar ; Nieto-Jiménez, Cristina ; Galán-Moya, Eva M....
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
5

Antitumoral activity of a CDK9 PROTAC compound in HER2-Posi..:

Noblejas-López, María del Mar ; Gandullo-Sánchez, Lucía ; Galán-Moya, Eva María...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2022
Link: http://hdl.handle.net/10..
 
?
6

MZ1 co-operates with trastuzumab in HER2 positive breast ca..:

Noblejas-López, María del Mar ; Nieto-Jiménez, Cristina ; Galán-Moya, Eva María...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2021
Link: http://hdl.handle.net/10..
 
?
7

TACkling Cancer by Targeting Selective Protein Degradation:

María del Mar Noblejas-López ; David Tébar-García ; Raquel López-Rosa...
https://www.mdpi.com/1999-4923/15/10/2442.  , 2023
Link: https://doi.org/10.3390/..
 
?
8

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Posi..:

María del Mar Noblejas-López ; Lucía Gandullo-Sánchez ; Eva M. Galán-Moya...
Molecular Oncology.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Posi..:

María del Mar Noblejas-López ; Lucía Gandullo-Sánchez ; Eva M. Galán-Moya...
https://www.mdpi.com/1422-0067/23/10/5476.  , 2022
Link: https://doi.org/10.3390/..
 
?
10

Pathogenic Microenvironment from Diabetic–Obese Visceral an..:

Lesgui Alviz ; David Tebar-García ; Raquel Lopez-Rosa...
https://www.mdpi.com/2072-6643/13/3/1032.  , 2021
Link: https://doi.org/10.3390/..
 
?
11

MZ1 co-operates with trastuzumab in HER2 positive breast ca..:

María del Mar Noblejas-López ; Cristina Nieto-Jiménez ; Eva M. Galán-Moya...
https://doi.org/10.1186/s13046-021-01907-9.  , 2021
Link: https://doi.org/10.1186/..
 
?
12

Pathogenic Microenvironment from Diabetic–Obese Visceral an..:

Lesgui Alviz ; David Tebar-García ; Raquel Lopez-Rosa...
Phytochemicals and Human Health.  , 2021
Link: https://doi.org/10.3390/..
 
?
13

Additional file 2 of MZ1 co-operates with trastuzumab in HE..:

María del Mar Noblejas-López (7331975) ; Cristina Nieto-Jiménez (6019319) ; Eva M. Galán-Moya (7331984)...
https://figshare.com/articles/journal_contribution/Additional_file_2_of_MZ1_co-operates_with_trastuzumab_in_HER2_positive_breast_cancer/14252020.  , 2021
Link: https://doi.org/10.6084/..
 
?
14

Additional file 1 of MZ1 co-operates with trastuzumab in HE..:

María del Mar Noblejas-López (7331975) ; Cristina Nieto-Jiménez (6019319) ; Eva M. Galán-Moya (7331984)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_MZ1_co-operates_with_trastuzumab_in_HER2_positive_breast_cancer/14252017.  , 2021
Link: https://doi.org/10.6084/..
 
?
15

Additional file 8 of MZ1 co-operates with trastuzumab in HE..:

María del Mar Noblejas-López (7331975) ; Cristina Nieto-Jiménez (6019319) ; Eva M. Galán-Moya (7331984)...
https://figshare.com/articles/presentation/Additional_file_8_of_MZ1_co-operates_with_trastuzumab_in_HER2_positive_breast_cancer/14252038.  , 2021
Link: https://doi.org/10.6084/..
 
1-15